Clinical Trial Update: Efficacy Analysis of Neoadjuvant Treatment in Lung Cancer Using Low-dose Nivolumab Combined With Chemotherapy [Phase 2]

View source ↗

Summary

This Phase 2 clinical trial evaluates the efficacy of low-dose nivolumab added to chemotherapy as neoadjuvant treatment for non-small cell lung cancer. The stud…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• nivolumab (Opdivo) (nivolumab)

Snippet

Sponsor: Aline Fusco Fares, MD | Conditions: Lung Cancer, Nonsmall Cell, Non-Small Cell Lung Cancer NSCLC | Phase 2 | Status: RECRUITING